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ABSTRACT Mouse trisomy 16 has been proposed as an
animal model of Down syndrome (DS), since this chromosome
contains homologues of several loci from the q22 band of
human chromosome 21. The recent mapping of the defect
causing familial Alzheimer disease (FAD) and the locus encod-
ing the Alzheiner amyloid (3 precursor protein (APP) to human
chromosome 21 has prompted a more detailed examination of
the extent ofconservation of this linkage group between the two
species. Using anonymous DNA probes and cloned genes from
human chromosome 21 in a combination ofrecombinant inbred
and interspecific mouse backcross analyses, we have estab-
lished that the linkage group shared by mouse chromosome 16
includes not only the critical DS region of human chroniosome
21 but also the APP gene and FAD-linked markers. Extending
from the anonymous DNA locus D21S52 to ETS2, the linkage
map of six loci spans 39% recombination in man but only 6.4%
recombination in the mouse. A break in synteny occurs distal
to ETS2, with the homologue of the human marker D21S56
mapping to mouse chromosome 17. Conservation of the linkage
relationships of markers in the FAD region suggests that the
murine homologue of the FAD locus probably maps to chro-
mosome 16 and that detailed comparison of the corresponding
region in both species could facilitate identification of the
primary defect in this disorder. The break in synteny between
the terminal portion of human chromosome 21 and mouse
chromosome 16 indicates, however, that mouse trisomy 16 may
not represent a complete model of DS.
Human chromosome 21, the smallest autosome comprising
1.9% of the genome, has been extensively characterized by
cytogenetic approaches and molecular techniques, including
the development of physical and genetic maps (1). A primary
impetus for this effort is the role of chromosome 21 in Down
syndrome (DS), one of the most common causes of mental
retardation (2). Karyotypic analyses of cases of partial
trisomy 21 have indicated that only part of the chromosome,
band 21q22, is required for full manifestation of the DS
phenotype (3-8). Though this region probably contains a few
hundred genes that could contribute to the disorder, an
unequivocal causal role has not yet been established for any
individual locus. However, since the syntenic relationship of
several candidate genes such as superoxide dismutase
(SOD1), the ets-2 protooncogene (ETS2), phosphoribosylgly-
cinamide synthetase (PRGS), and the interferon receptors
(IFNAR and IFNBR) has apparently been conserved in the
mouse genome, mouse trisomy 16 has been used as an animal
model of DS (9, 10).
Interest in human chromosome 21 has increased with the
recent localizations of the defect causing familial Alzheimer
disease (FAD) and the gene (APP) encoding the precursor for
amyloid ,8 protein to the proximal half of 21q (11, 12). FAD
is the autosomal dominantly inherited form of the common
late-onset neurodegenerative disorder that results in the
gradual and devastating impairment of memory and cogni-
tion. Amyloid f3 protein is a major component of the neuritic
plaques seen in sporadic and inherited forms of Alzheimer
disease (AD) and in DS. To assess the potential utility of
mouse chromosome 16 in the investigation ofAD and DS, we
have compared the genetic linkage relationships of the
murine homologues of a number of loci spanning 21q,
including the genes APP, SOD), and ETS2 and several
cross-hybridizing anonymous DNA loci.
METHODS
Mice. Progenitor inbred mouse strains AKR/J, C57BL/6J,
C3H/HEJ,, C57L/J, and DBA/2J and the recombinant inbred
(RI) sets AKXD, AKXL, BXD, and BXH were purchased
from The Jackson Laboratory. Recombination estimates and
95% confidence intervals (CIs) for the RI analysis were
determined from Silver (13).
Interspecific Backcross. C57BL/6J - Re Trl + + females
crossed to Mus spretus [Spain] males and F1 hybrid females
were backcrossed to C57BL/6J males. Genomic DNAs from
each backcross progeny were prepared from samples of
spleen and liver as described (14). Approximate 95% CIs on
the estimated recombination frequency were calculated as
described (15).
DNA Probes and Southern Blot Hybridization. The human
chromosome 21 probes tested for cross-hybridization were
pGSE9 (D2JS16), 511-lH/511-2P (D21S52), pPW228C
(D2151), pPW245D VD21S8), FB68L and HL124 (APP),
pSG1-10 (SOD)), 524-5P (D21S58), H33 (ETS2), 520-1OR
(D21S56), pGSE8 (D215J), pPW231C (D2153), and
pPW242B (D21S7) (12, 16-21). DNA probes were prepared
and labeled for hybridization to Southern blots of genomic
DNA digested with 10-35 restriction enzymes as described
(22, 23).
Glo Typing. The BXD RI strains were characterized with
respect to quantitative variation in erythrocyte glyoxylase
Abbreviations: DS, Down syndrome; FAD, familial Alzheimer
disease; RFLP, restriction fragment length polymorphism; SDP,
strain distribution pattern; CI, confidence interval; RI, recombinant
inbred.
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activity, which results from a cis-acting element that maps to
the Glo-i structural gene locus (24). To facilitate classifica-
tion, each BXD strain was outcrossed to the SWR/J strain,
which bears the Glo-lb electrophoretic variant. The relative
contribution of the Glo-la allele from the BXD strain to the
Glo-Pa/Gbo-lb allozyme pattern was compared to (SWR/J x
C57BL/6J)F1 and (SWR/J x DBA/2J)F1 controls. RI strains
with relatively little GLO-lA homodimer were judged to
carry the C57BL/6J allele and strains with relatively more of
the GLO-lA homodimer were judged to carry the DBA/2J
allele.
RESULTS
To define the murine counterparts for the DS and FAD
chromosomal regions, probes for human chromosome 21
DNA loci spanning 21q were employed for restriction frag-
ment length polymorphism (RFLP) linkage analysis in the
mouse. The murine homologues for SOD] and ETS2, Sod-i
and Ets-2, respectively, have previously been localized to the
distal portion of mouse chromosome 16. These human loci
from 21q22 are considered markers for the region of chro-
mosome 21 associated with manifestation of the DS pheno-
type (9, 10).
The linkage relationships of the murine homologues de-
tected by the human chromosome 21 probes were initially
assessed by using four sets of RI strains (25), each derived by
inbreeding the progeny of a cross between two parental
inbred strains. Comparison of the strain distribution patterns
(SDPs) of the genotypes for any two loci with differing
parental genotypes provides a measure of their linkage
relationship, thereby allowing the rapid chromosomal local-
ization of new loci relative to those previously typed in the
same RI sets.
Each human DNA probe was checked by Southern blot
analysis for its degree of cross-hybridization to DNA from
the progenitor inbred mouse strains. The potential for using
anonymous human DNA RFLP markers for interspecies
mapping depends on the extent of divergence in the homol-
ogous DNA sequences between the two species. In general,
coding sequences would be expected to show less divergence
than noncoding sequences. Therefore, anonymous DNA
markers that show cross-hybridization are more likely to
contain coding sequences. Only seven of the chromosome 12
DNA markers tested (see Methods) showed reproducible
cross-hybridization to mouse DNA: the genes SOD), ETS2,
and APP and the anonymous DNA sequences D21S16,
D21S52, D21S56, and D21S58.
Subsequently, the cross-hybridizing markers were
screened for RFLPs by hybridizing under nonstringent con-
ditions to Southern blots containing up to 35 restriction
enzyme digests of genomic DNA from a series of inbred
mouse strains: A/J, AKR/J, C57B3L/6J, C3H/HeJ, C57L/J,
DBA/2J, and SJL/J. With the exception of ETS2 and
D21S58, the markers revealed RFLPs (Table 1) in the
progenitor inbred strains making them useful for analysis of
some RI lines with representatives of the DS (SOD), APP,
D21556) and FAD regions (D21i16, D215S2). An example of
the polymorphic cross-hybridizing Southern blot signal de-
tected by a human DNA probe is illustrated in Fig. 1A, where
a cDNA probe for APP revealed a Msp I RFLP between the
C57BL/6J and the DBA/2J progenitor mouse strains.
For each marker displaying a RFLP in the mouse, geno-
types of individual RI strains from the appropriate RI sets
(AKXD, AKXL, BXD, and BXH) were determined. The
SDPs for these markers are presented in Table 2. Comparison
of these to the SDPs for a bank of400 previously mapped loci
was performed to assign chromosomal locations for the DNA
markers. For the anonymous human DNA markers, we have
used the human locus symbol to identify the homologous
murine locus. For the homologue of the APP locus, we
propose the symbol App.
The results of the RI analysis in the BXD and AKXD sets
revealed that App and D21J16 are closely linked with six
differences among 49 lines, corresponding to a genetic
separation of 3.7% recombination (CI = 1.6-9.9). However,
these markers each displayed eight differences with the SDP
for Sod-i in 26 strains of the BXD set of RI strains, though
their human homologues display relatively close linkage. It
was not possible to exclude these loci from chromosome 16
because ofthe paucity ofpreviously assigned markers for this
chromosome. Furthermore, App, D21S16, and D215S2 gave
negative linkage scores for markers on all other chromo-
somes, making it impossible to assign their chromosomal
location.
Table 1. RFLPs used in RI mouse strains and interspecific backcross linkage analysis
Inbred strains Interspecific backcross
Restriction RI strain Polymorphic Constant Restriction M. spretus C57BL/6J
Locus enzyme progenitors* fragments, kb fragments, kb Locus enzyme fragments, kb fragments, kb
D21S16 Bgi II A, B 4.6 - D21S16 Xba I 8.2 3.7
D 3.3 App Xba I 7.8 3.8
BamHI A, B 18.0 D21S52 Xba I 10.1 4.4
D 7.3 Sod-i Pvu II 4.3 8.6, 7.0, 6.4
App Msp I D, H 4.0 3.9, 2.7, 2.0, D21S58 Taq I 3.8, 1.8 2.3, 1.2
0.6, 0.4
A, B 2.4 3.9, 2.7, 2.0, Ets-2 BamHI 3.2 8.0
0.6, 0.4
D21S52 Taq I A 3.5
L 2.3
Pvu II L 6.3
A 3.2
Sod-i Pst I B, L 15.0 5.6, 5.8
A, D 9.5 5.6, 5.8
BamHI B, L 10.5 19.0
A, D 8.0 19.0
D21S56 Xmn I A, D, H 9.4 18.0
B, L 8.0 18.0
kb, Kilobases.
*A, AKR/J; B, C57BL/6J; D, DBA/2J; H, C3H/HEJ; L, C57L/J.
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The RI analysis provided a chromosome assignment for
D21S56, which showed significant linkage with loci in the
proximal region of chromosome 17. D21S56 is tightly linked
to the quantitative variant of the glyoxylase-1 (Glo-i) locus,
with no recombinants in 26 informative RI strains. Similarly,
D21S56 maps 5.4% recombination (CI = 2.6-12.7) distal to
Hba-4ps, the hemoglobin a-chain pseudogene locus (nine
differences in 55 RI strains), 0.6% recombination (CI = 0.02-
3.8) from Pim-), the preferred integration site for mink cell
focus-forming viruses (one difference in 43 strains), 1.0%
recombination (CI = 0.03-7.0) from Crya-J, the lens a-
crystallin locus (one difference in 26 strains),'and 2.6%
recombination- (CI = 11-7.0) proximal to H-2, the major
histocompatibility locus (five differences in 56 strains) (26-
31). The data are most consistent with the gene order
Hba-4ps-(Glo-i, D21S56)-Pim-1-Crya-J-H-2. However,
since the placement of GM-i and D21S56 proximal to Pim-l
is based on a single crossover strain, alternative'arrange-
ments are possible.
Although RI analysis is a rapid method for detecting
genetic linkage, classical backcross analysis provides greater
sensitivity for larger recombination fractions and a more
reliable means ofdetermining the relative order ofthe various
markers. Therefore, we used an interspecific backcross
between C57BL/6J and M. spretus [Spain] to firmly establish
that all of the cross-hybridizing loci except D21S56 reside on
chromosome 16 and to determine their map order. The use of
an interspecific' backcross, which in this case involved
breeding C57BL/6J males with the' F1 female offspring of an
interspecific cross between C57BL/6J and M. spretus
[Spain], is' more efficient than one involving 'only inbred
strains due to the increased likelihood of finding segregating
RFLPs for each marker locus (32). RFLPs distinguishing the
Table 2. RI SDPs for mouse homologues of human chromosome 21 loc
parental mouse strains for each of the cross-hybridizing
probes were identified by screening with up to 10 restriction
enzymes (Table 1) and were subsequently used for linkage
analysis using a combination of 63 progeny of the backcross
(Fig.' 1B and Table 3).
Significant linkage was detected among all six loci signi-
fying the conservation of an extended''syntenic group on
mouse chromosome 16 and hum'an'chromosome 21. One
crossover separated Ets-2 from all the other loci. Three
additional crossovers split the loci into two groups: (Ets-2,
Sod-], D2JSS8) and (App, D2JSJ6, D21S52). Taken together,
these data suggest the order (App, D2iS16, D21S52)-
(D2iS58, Sod-i)-Ets-2 (Table 3). This linkage group spans
6.4% recombination (CI = 2.0-15.0) with Ets-2 being 1.6%
recombination (CI = 0.01-8.0) from the (D2iS58, Sod-i)
cluster.
The 4.8% recombination observed between Sod-i and App
in the backcross contrasts with the inability to prove linkage
of these markers' by the less-sensitive RI analysis. At this
genetic distance, we would have expected 4 of 26 RI strains
to 4iffer between the two loci, corresponding to-a recombi-
nation frequency of5.0%, with 95% confidence limits of 1.2%
to 18.3%. The observed eight differences in the SDPs predict
a recombination frequency of 14.3%, which is well within
these confidence limits. However, although' the RI data are
consistent with the backcross analysis, it is not by itself
sufficient to prove linkage. Similarly, the estimate of 3.7%
recombination between App and D21SI6 from the RI analysis
appears to be at odds with the failure to detect any crossovers
in 63 backcross progeny. However, the probability of such an
occurrence is about 9% if the recombination estimate is
accurate and as high as 50% if the lower confidence limit of
this estimate is the truie value.
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Table 3. Interspecific backcross linkage: allelic combinations
inherited from the F1 parent
Allelic combination Loci n
D21S16 Sod-i Ets-2
D21S52 D21S58*
App
Parental B B B 23
S S S 36
Recombinant B B x S 0
S S x B 1
B x S S 2
S x B B 1
Total 63
*Due to lack ofDNA, D21S58 was typed in 58 of the F1 progeny. The
five mice not typed included four showing no recombination
between any of the other markers and one of the "B S S"
recombinant type.
A comparison of the interspecific mouse linkage map with
the human female linkage map (refs. 17, 33; J.F.G., unpub-
lished data) shows the extent of the syntenic region shared by
the two species (Fig. 2). The order of the loci in the mouse is
consistent with the established order of the human loci
extending from the 21q11 band through 21q22.3: (D21S52,
D21S16)-APP-SODJ-D21S58-ETS2, thereby demonstrating
linkage as well as synteny conservation. In man, however,
the linkage group spans a much larger genetic distance of
=39% recombination. The relative compression of the syn-
tenic group in the mouse is due to a lack of recombination
between D21S16 and App, whose homologues display 16%
recombination in the human female, and to much tighter
linkage of Sod-i and Ets-2 than their human homologues. By
contrast, the linkage distance between the amyloid precursor
protein gene and the superoxide dismutase locus is relatively
similar in both species. Results of the RI analysis giving a
genetic distance of 3.7% recombination (CI = 1.6-9.9)
between App and D21S16 suggest that apparent compression
4
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FIG. 2. Comparison of the syntenic linkage maps of human
chromosome 21 and mouse chromosome 16. The illustrated mouse
genetic linkage map of chromosome 16 was constructed by using the
interspecific backcross data for comparison with the previously
established linkage map of human chromosome 21 (17, 33). Genetic
distance is given as recombination frequency. Since sex-specific
differences in recombination frequency have been observed on
human chromosome 21, the map displays the recombination fre-
quency for human female meioses (all F1 animals in the backcross
were female). The relative order of loci within brackets is not known.
of the interspecific linkage map in this particular region could
be due in some degree to the interspecific nature of the
backcross.
In the human, the frequency of recombination on 21q
increases dramatically toward the telomere (17, 33), resulting
in an estimated 29% recombination between ETS2 and
D21S56, both located in the terminal 21q22.3 subband.
Within this region there is a break in synteny with the mouse,
since D21S56 maps unequivocally to mouse chromosome 17.
DISCUSSION
Mapping of the human and mouse genomes has revealed the
existence of conserved linkage relationships for many genes,
with syntenic stretches averaging about 8.1 + 1.6 centimor-
gans in the mouse (34, 35). Consequently, the murine homo-
logues of human genes associated with specific genetic
disorders may often be present in a conserved linkage group
of significant size, creating the potential for generating new
insights into the human disorder by detailed comparative
analysis of the homologous mouse region. For disorders
involving gene dosage, such as DS, the development of an
accurate mouse model also becomes a possibility. Previous
studies have established that mouse chromosome 16 contains
some genes whose human homologues reside in 21q22, the
critical DS region ofchromosome 21, and have led to directed
attempts to produce mice with trisomy 16. These do not
survive as live-born animals but do display some phenotypic
features reminiscent of the human disorder (9).
Recent molecular genetic investigations have also impli-
cated chromosome 21 in AD, a common late-onset neurode-
generative disorder producing progressive dementia. The
defect causing the inherited form ofAD has been assigned by
linkage analysis to chromosome 21 (11). In addition, the gene
encoding the precursor of the amyloid , protein observed in
the senile plaques ofAD has been cloned and mapped to this
autosome (12). The fact that aged DS patients also develop
AD-like neuropathology suggests that AD may involve over-
expression of a gene in the proximal portion of 21q.
To explore the potential for mouse trisomy 16 to act as a
model of DS and AD, we have expanded and constructed a
detailed linkage map for the region of synteny with human
chromosome 21. Overall, loci spanning at least 39% recom-
bination ofthe long arm ofhuman chromosome 21 are present
on mouse chromosome 16. The three identified genes in-
cluded in the analysis, APP, SOD], and ETS2, all lie in the
region ofchromosome 21 associated with manifestation ofthe
DS phenotype and are present in the same relative order on
mouse chromosome 16. Considering the previously mapped
biochemical markers PRGS, IFNAR, and IFNBR, six genes
have now been mapped to these homologous chromosome
regions.
The inclusion of anonymous DNA sequences in the linkage
analysis has revealed that the region of homology extends to
D2JS16 and D21S52, markers linked to FAD, raising the
possibility that mouse chromosome 16 contains a normal
homologue of the FAD locus. Identification of coding se-
quences in genomic DNA is often facilitated by assessing the
relative degree of conservation of particular sequences be-
tween man and mouse (36). Detailed molecular comparison of
corresponding mouse and human regions surrounding the
disease gene might therefore hasten identification of the
primary defect in FAD.
In the mouse, the shared loci retain the same order as in the
human but span just 6.4% recombination. Even allowing for
general differences in recombination frequency in the two
species, this number is still surprisingly low. A similar
apparent condensation of the genetic map has been reported
by Reeves et al. (37), who used a cross between the inbred
Mus musculus domesticus (BALB) and the wild-derived
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subspecies Mus musculus musculus (Czech II) to estimate
the genetic distance between Sod-i and Ets-2. These inves-
tigators observed only one crossover in 86 chances when
(Czech II x BALB/cPt)Fl females were backcrossed with
Czech II males. When the same distance was estimated from
a backcross involving two inbred strains [(BALB/cBy x
CBA/J) x BALB/cByI, five recombinations were detected
in 61 events (37). The presence of a small inversion involving
one of the flanking markers could have the effect of sup-
pressing recombination without obviously changing the gene
order (14, 38). An alternative explanation is that the region
between D21S16 and APP in the human contains additional
DNA sequences not present on mouse chromosome 16,
thereby increasing the relative genetic distance between the
two loci. This would have profound significance for the use
of trisomy 16 as a model of DS, since some of this additional
material on chromosome 21 might contribute to the DS
phenotype.
The conserved linkage group does not involve the entire
21q arm, as there is a break in synteny distal to ETS2, with
the homologue ofD21S56 mapping to mouse chromosome 17.
Recently, two other loci from the terminal region of 21q22,
CRYA, encoding lens crystallin a A (29, 39, 40), and CBS,
encoding cystathionine f3-synthetase (41), have been re-
ported to have mouse homologues in the proximal portion of
mouse chromosome 17, placing them close to D21S56. This
suggests that some genes associated with the DS phenotype
may not have homologues on mouse chromosome 16. Tris-
omy for this mouse chromosome may not, therefore, provide
a complete model for the human disorder, and the effect of
increased dosage for genes from the region ofchromosome 17
homologous to human 21q22 warrants investigation.
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